Random Antimicrobial Peptide Mixtures for Resistant Infections

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current strategies for managing bacterial and fungal infections, particularly in agriculture, are inadequate due to issues like toxicity, cost, and resistance development, necessitating new eco-friendly and effective antimicrobial solutions.

Innovation Solution

Development of random antimicrobial peptide mixtures (RPMs) composed of hydrophobic and cationic amino acids, optionally conjugated to fatty moieties, which exhibit broad-spectrum antimicrobial activity with a low probability of resistance development.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antimicrobial agents (chemicals and biologicals) are used to control fungal and bacterial infections, then antimicrobial activity is achieved, but toxicity, cost, and resistance development occur

Engineering Contradiction:
Improveantimicrobial activityVSAvoidtoxicity and resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameters by using peptide-based antimicrobials with specific amino acid compositions (hydrophobic and cationic residues) instead of conventional chemicals. This parameter change enables broad-spectrum activity against bacteria and fungi while reducing toxicity and resistance development, as the peptide structure allows for natural degradation and lacks the selective pressure that drives resistance in conventional antimicrobials.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite peptide structures by combining hydrophobic amino acids (e.g., phenylalanine, leucine, isoleucine) with cationic amino acids (e.g., lysine, arginine, histidine) in specific ratios. This composite approach generates peptides with enhanced antimicrobial activity and reduced harmful effects, as the combination provides both membrane disruption capability and selective toxicity.

Inventive Principle:
Principle #40Composite materials

2Reliability

If peptide mixtures are synthesized to achieve broad-spectrum antimicrobial activity, then effectiveness against resistant strains is improved, but synthesis complexity increases

Engineering Contradiction:
Improvebroad-spectrum antimicrobial activityVSAvoidsynthesis complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the antimicrobial peptide into two functional components: hydrophobic amino acids that provide membrane disruption and cationic amino acids that provide electrostatic interaction with bacterial membranes. By segmenting the peptide design into these functional modules, the patent achieves broad-spectrum activity while simplifying the synthesis process, as each component can be independently optimized and combined in standard peptide synthesis protocols.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent creates universal peptide mixtures that can effectively target multiple types of microorganisms (Gram-positive and Gram-negative bacteria, fungi) through a single formulation. The peptides are designed to perform multiple functions: electrostatic interaction with anionic bacterial membranes, membrane disruption via hydrophobic residues, and pore formation. This multi-functionality reduces the need for multiple specialized antimicrobials, simplifying the overall treatment approach.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If copper-based bactericides are used to control bacterial infections, then bactericidal activity is achieved, but microbial toxicity and environmental concerns increase

Engineering Contradiction:
Improvebactericidal activityVSAvoidmicrobial toxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent employs peptide-based antimicrobials that are biodegradable and environmentally friendly, replacing persistent copper-based bactericides. The peptide structure is designed to be naturally degraded by proteases and other biological processes, eliminating long-term environmental contamination. The peptides provide effective bactericidal activity during their functional period and then naturally decompose, avoiding the accumulation and bioaccumulation issues associated with metal-based antimicrobials.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

RPMs provide potent and cost-effective antimicrobial activity against a wide range of bacteria and fungi, including resistant strains, with enhanced efficacy when conjugated to fatty moieties, effectively inhibiting growth and proliferation.

Implementation Method 1

The copper metal/copper oxide matrix is configured to release copper ions therefrom together with the RPM

Methodology Applied
Scientific EffectCorrosion:

Implementation Method 2

HDPs display a characteristic selectivity, favoring attack on prokaryotic membranes relative to eukaryotic membranes. This selectivity is thought to arise from the net cationic charge common to HDPs, since the external surfaces of prokaryotic cells typically have a larger net negative charge than do the external surfaces of eukaryotic cells.

Methodology Applied
Scientific EffectElectrostatic interaction: Electrostatics

Implementation Method 3

HDPs are rich in hydrophobic residues, which presumably mediate disruptive interactions with the hydrophobic interior of a lipid bilayer.

Methodology Applied
Scientific EffectHydrophobic effect: Hydrophobe

Data Source

PatentUS20230256102A1Composites and uses thereof
Publication Date: 2023.08.17 YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD
  • US20230256102A1 patent drawing
  • US20230256102A1 patent drawing
  • US20230256102A1 patent drawing

AI summary

The invention generally concerns active peptide mixture and composites thereof.